{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:16Z","timestamp":1761515416539,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.4158\/ep.12.5.506","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:42:20Z","timestamp":1365198140000},"page":"506-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and Treatment of Anemia With Once-Weekly Epoetin Alfa in Patients With Diabetes and Chronic Kidney Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Daniel L.","family":"Lorber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"McClellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.12.5.506_bb0005","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0140-6736(00)04728-0","article-title":"Progression, remission, regression of chronic renal diseases","volume":"357","author":"Ruggenenti","year":"2001","journal-title":"Lancet."},{"key":"10.4158\/EP.12.5.506_bb0010","unstructured":"National Kidney Foundation, Inc. Under-diagnosed medical condition threatens more than 40 million Americans with kidney failure: new guidelines urge physicians to use routine blood and urine tests to diagnose chronic kidney disease when it can be treated. Available at: http:\/\/www.kidney.org\/news\/newsroom\/newsitem.cfm7id=180. Accessed for verification July 30, 2006."},{"issue":"Suppl 7","key":"10.4158\/EP.12.5.506_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ndt\/16.suppl_7.61","article-title":"Chronic kidney disease: why is current management uncoordinated and suboptimal?","volume":"16","author":"Valderrabano","year":"2001","journal-title":"Nephrol Dial Transplant."},{"issue":"Suppl 5","key":"10.4158\/EP.12.5.506_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/16.suppl_5.11","article-title":"Renal disease in type 2 diabetes","volume":"16","author":"Ritz","year":"2001","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP.12.5.506_bb0025","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"McClellan","year":"2004","journal-title":"Curr Med Res Opin."},{"key":"10.4158\/EP.12.5.506_bb0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1681\/ASN.V132504","article-title":"Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey","volume":"13","author":"Hsu","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP.12.5.506_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJM198907203210305","article-title":"Treatment of the anemia of progressive renal failure with recombinant human erythropoietin","volume":"321","author":"Eschbach","year":"1989","journal-title":"N Engl J Med."},{"issue":"1 Suppl 1","key":"10.4158\/EP.12.5.506_bb0040","first-page":"S182","volume":"37","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.12.5.506_bb0045","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","article-title":"Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis","volume":"2","author":"Winearls","year":"1986","journal-title":"Lancet."},{"key":"10.4158\/EP.12.5.506_bb0050","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V12112465","article-title":"Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%","volume":"12","author":"Collins","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP.12.5.506_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.12.5.506_bb0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2001.21305","article-title":"Use of erythropoietin before the initiation of dialysis and its impact on mortality","volume":"37","author":"Fink","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.12.5.506_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ndt\/16.2.307","article-title":"Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients","volume":"16","author":"Jungers","year":"2001","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP.12.5.506_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0272-6386(00)70334-9","article-title":"Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure","volume":"35","author":"Hayashi","year":"2000","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.12.5.506_bb0075","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0272-6386(99)70150-2","article-title":"Normalizing hematocrit in dialysis patients improves brain function","volume":"33","author":"Pickett","year":"1999","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.12.5.506_bb0080","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.1990.03440060071035","article-title":"The quality of life of hemodialysis recipients treated with recombinant human erythropoietin","volume":"263","author":"Evans","year":"1990","journal-title":"JAMA"},{"key":"10.4158\/EP.12.5.506_bb0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/oxfordjournals.ndt.a092496","article-title":"Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin","volume":"8","author":"Barany","year":"1993","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP.12.5.506_bb0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-110-2-108","article-title":"Recombinant human erythropoietin treatment in pre-dialysis patients: a double-blind placebo-controlled trial","volume":"110","author":"Lim","year":"1989","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.12.5.506_bb0095","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5414\/CNP61392","article-title":"(POWER Study Group). Once-weekly epoetin alfa for treating the anemia of chronic kidney disease","volume":"61","author":"Provenzano","year":"2004","journal-title":"Clin Nephrol."},{"key":"10.4158\/EP.12.5.506_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"(National Kidney Foundation). National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification [erratum in Ann Intern Med. 2003;139: 605]","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.12.5.506_bb0105","first-page":"3412","article-title":"Cella D (Procrit Study Group)","volume":"16","author":"Demetri","year":"1998","journal-title":"Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol."},{"key":"10.4158\/EP.12.5.506_bb0110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0277-5379(83)90042-1","article-title":"Assessment of the quality of life of patients with advanced cancer","volume":"19","author":"Gough","year":"1983","journal-title":"Eur J Cancer Clin Oncol."},{"key":"10.4158\/EP.12.5.506_bb0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000186769","article-title":"A disease-specific questionnaire for assessing quality of life in patients on hemodialysis [erratum in Nephron. 1992;61: 248]","volume":"60","author":"Laupacis","year":"1992","journal-title":"Nephron."},{"issue":"4 Suppl","key":"10.4158\/EP.12.5.506_bb0120","doi-asserted-by":"crossref","first-page":"168S","DOI":"10.1016\/S0197-2456(05)80021-2","article-title":"(Canadian Erythropoietin Study Group). The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin","volume":"12","author":"Laupacis","year":"1991","journal-title":"Control Clin Trials."},{"key":"10.4158\/EP.12.5.506_bb0125","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1523-1755.2005.00226.x","article-title":"(Kidney Early Evaluation Program). Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency","volume":"67","author":"El-Achkar","year":"2005","journal-title":"Kidney Int."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/8FUECBC4EV92XAPG.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:46:58Z","timestamp":1761515218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20422803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1530891X20422803"],"URL":"https:\/\/doi.org\/10.4158\/ep.12.5.506","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Treatment of Anemia With Once-Weekly Epoetin Alfa in Patients With Diabetes and Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.12.5.506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}